Josef Karner

Josef Karner is a researcher at the Salk Institute's Department of Radiotherapy and Radiation Oncology, focusing on advanced cancer treatments. His work bridges radiation oncology and immunotherapy with machine learning applications.

• Research Interests: Radiation therapy optimization, NSCLC treatment, immunotherapy integration, machine learning in imaging, and pulmonary toxicity prediction.

Publication Trends: Recent articles (2023–2025) emphasize non-small cell lung cancer (NSCLC) and prostate cancer, with methodological innovations in Cone-Beam CT segmentation using U-Net and Transformer architectures. Clinical studies focus on chemoimmunotherapy protocols and DLCO thresholds for radiation-induced pneumonitis.